Results 121 to 130 of about 8,213 (210)

FM1-43 dye behaves as a permeant blocker of the hair-cell mechanotransducer channel [PDF]

, 2001
Hair cells in mouse cochlear cultures are selectively labeled by brief exposure to FM1-43, a styryl dye used to study endocytosis and exocytosis. Real-time confocal microscopy indicates that dye entry is rapid and via the apical surface.
Gale, J.E., Kennedy, H.J., Kros, C.J., Marcotti, W., Richardson, G.P.   +4 more
core   +1 more source

The Impact of Oleuropein on Cisplatin-Induced Toxicity in Cochlear Cells in Relation to the Expression of Deoxyribonucleic Acid Damage-Associated Genes

Journal of International Advanced Otology
BACKGROUND: Different organs respond differently to cisplatin (CDDP)-induced toxicity. Oleuropein (OLE) is a natural phenolic antioxidant. The purpose of this study was to determine the potential protective effect of OLE against CDDP-induced ototoxicity ...
Yüksel Olgun, Zekiye Altun, Merve Tütüncü, Selen Kum Özşengezer, Safiye Aktaş, Enis Alpin Güneri   +5 more
doaj   +1 more source

Ototoxicity: Early Detection and Monitoring

The ASHA Leader, 2005
Dawn Konrad-Martin, Wendy J. Helt, Kelly M. Reavis, Jane S. Gordon, Laura L. Coleman, Gene W. Bratt, Stephen A. Fausti   +6 more
openaire   +1 more source

Incorporating Vestibular Evoked Myogenic Potential (VEMP) assessment into our clinical practice [PDF]

, 2008
Vestibular Evoked Myogenic Potentials (VEMPs) are short-latency electromyographic responses evoked by intense acoustic stimuli. They are measured in the ipsilateral, tonically-contracted sternocleidomastoid (SCM) muscle.
Jackson, Jacquelyn
core  

Mobile Audiometry for Use in Ototoxicity Monitoring Programs: A Scoping Review. [PDF]

J Audiol Otol
Yim PWC, Lim ZH.
europepmc   +1 more source

Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology. [PDF]

Int J Audiol, 2018
Garinis AC, Cornell A, Allada G, Fennelly KP, Maggiore RJ, Konrad-Martin D.   +5 more
europepmc   +1 more source

Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions. [PDF]

Int J Audiol, 2018
Konrad-Martin D, Poling GL, Garinis AC, Ortiz CE, Hopper J, O'Connell Bennett K, Dille MF.   +6 more
europepmc   +1 more source

Survivors’ perspectives on cisplatin-induced ototoxicity and barriers to ototoxicity monitoring

Journal of Cancer Survivorship
Lee, David S., Mueller, Lauren, Wong, Susan K., Travis, Emma Y., Munyemana, Marie-Ange, Mazul, Angela L., McClannahan, Katrina S., Jeffe, Donna B., Lieu, Judith E.   +8 more
openaire   +1 more source

Tobramycin population pharmacokinetics in neonates [PDF]

, 1997
Anker, J.N. (John) van den, Hoog, M. (Matthijs) de, Mouton, J.W. (Johan), Schoemaker, R.C. (Rik)   +3 more
core   +1 more source

Early Detection of Ototoxicity Using Serial Mobile Audiometry, Otoacoustic Emissions Testing, and Inner Ear Biomarker Measurement in Patients Receiving Platinum-Based Chemotherapy Treatment: It is Feasible to Implement in a National Health Service (NHS) Cancer Ambulatory Care Setting. [PDF]

Otol Neurotol
Mehta N, Awad A, Forbes M, Iliadou E, Katiri R, Ferdous T, Lowe H, Ensell L, Alifrangis C, Schilder AGM, Windsor R.   +10 more
europepmc   +1 more source